McFarland Matthew J, Porter Amy C, Rakhshan Fariborz R, Rawat Diwan S, Gibbs Richard A, Barker Eric L
Department of Medicinal Chemistry and Molecular Pharmacology, Purdue University, West Lafayette, Indiana 47907-2091, USA.
J Biol Chem. 2004 Oct 1;279(40):41991-7. doi: 10.1074/jbc.M407250200. Epub 2004 Aug 3.
The mechanisms responsible for the uptake and cellular processing of the endogenous cannabinoid anandamide are not well understood. We propose that anandamide uptake may occur via a caveola/lipid raft-related endocytic process in RBL-2H3 cells. Inhibitors of caveola-related (clathrin-independent) endocytosis reduced anandamide transport by approximately 50% compared with the control. Fluorescein derived from fluorescently labeled anandamide colocalized with protein markers of caveolae at early time points following transport. In this study, we have also identified a yet unrecognized process involved in trafficking events affecting anandamide following its uptake. Following uptake of [(3)H]anandamide by RBL-2H3 cells, we found an accumulation of tritium in the caveolin-rich membranes. Inhibitors of both anandamide uptake and metabolism blocked the observed enrichment of tritium in the caveolin-rich membranes. Mass spectrometry of subcellular membrane fractions revealed that the tritium accumulation observed in the caveolin-rich membrane fraction was not representative of intact anandamide, suggesting that following metabolism by the enzyme fatty acid amide hydrolase (FAAH), anandamide metabolites are rapidly enriched in caveolae. Furthermore, HeLa cells, which do not express high levels of FAAH, showed an accumulation of tritium in the caveolin-rich membrane fraction only when transfected with FAAH cDNA. Western blot and immunocytochemistry analyses of RBL-2H3 cells revealed that FAAH was localized in intracellular compartments distinct from caveolin-1 localization. Together, these data suggest that following uptake via caveola/lipid raft-related endocytosis, anandamide is rapidly metabolized by FAAH, with the metabolites efficiently recycled to caveolin-rich membrane domains.
内源性大麻素花生四烯乙醇胺的摄取及细胞处理机制尚未完全明确。我们推测,花生四烯乙醇胺的摄取可能通过RBL - 2H3细胞中与小窝/脂筏相关的内吞过程发生。与对照相比,小窝相关(网格蛋白非依赖性)内吞作用的抑制剂使花生四烯乙醇胺的转运减少了约50%。在转运后的早期时间点,荧光标记的花生四烯乙醇胺衍生的荧光素与小窝的蛋白质标记物共定位。在本研究中,我们还确定了一个尚未被认识的过程,该过程参与了花生四烯乙醇胺摄取后影响其运输的事件。RBL - 2H3细胞摄取[(3)H]花生四烯乙醇胺后,我们发现富含小窝蛋白的膜中有氚的积累。花生四烯乙醇胺摄取和代谢的抑制剂均阻断了在富含小窝蛋白的膜中观察到的氚富集。亚细胞膜组分的质谱分析表明,在富含小窝蛋白的膜组分中观察到的氚积累并不代表完整的花生四烯乙醇胺,这表明在脂肪酸酰胺水解酶(FAAH)代谢后,花生四烯乙醇胺代谢产物迅速在小窝中富集。此外,不高表达FAAH的HeLa细胞,只有在转染FAAH cDNA后才在富含小窝蛋白的膜组分中显示出氚的积累。对RBL - 2H3细胞的蛋白质印迹和免疫细胞化学分析表明,FAAH定位于与小窝蛋白-1定位不同的细胞内区室。总之,这些数据表明,通过与小窝/脂筏相关的内吞作用摄取后,花生四烯乙醇胺被FAAH迅速代谢,代谢产物有效地循环到富含小窝蛋白的膜结构域。